ORAL CONTRIBUTED SESSION 01: Clinical Trials I
Tracks
PARALLEL HALL 1 (Maurice Saltiel I & II Hall)
| Monday, July 22, 2024 |
| 11:00 AM - 12:31 PM |
| PARALLEL HALL 1 (Maurice Saltiel I & II Hall) |
Presentations
Ms. Linxi Han
University of Bristol
OC01-1 | SEMAP-curvature: A model-free Bayesian approach for analysis of dose-finding trials
11:00 AM - 11:18 AM
Ms. Chiara Micoli
Phd Student
Karolinska Institutet, Stockholm, Sweden
OC01-2 | Bayesian predictive probability of success for interim monitoring of clinical trials with competing risks data
11:18 AM - 11:36 AM
Mr. Alexander Ooms
Octru Senior Medical Statistician
University of Oxford, United Kingdom
OC01-3 | A real-time Bayesian re-design of a prostate cancer detection randomised controlled trial
11:36 AM - 11:54 AM
Mr. Christopher Selman
Murdoch Children's Research Institute, Parkville, Australia
OC01-4 | Evaluating the performance of Bayesian cumulative logistic models in randomised controlled trials: A simulation study
11:54 AM - 12:12 PM
Dr. Robert Mahar
University of Melbourne, Australia
OC01-5 | Approximate Bayesian-frequentist power in platform trial design
12:12 PM - 12:30 PMChair
Nicky Best
VP, Statistics & Data Science Innovation Hub
GSK, London, United Kingdom
